These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15088627)

  • 1. A plea for the analysis of Vitamin-D levels in patients under photoprotection, including patients with xeroderma pigmentosum (XP) and basal cell nevus syndrome (BCNS).
    Querings K; Reichrath J
    Cancer Causes Control; 2004 Mar; 15(2):219. PubMed ID: 15088627
    [No Abstract]   [Full Text] [Related]  

  • 2. Normal vitamin D levels can be maintained despite rigorous photoprotection: six years' experience with xeroderma pigmentosum.
    Sollitto RB; Kraemer KH; DiGiovanna JJ
    J Am Acad Dermatol; 1997 Dec; 37(6):942-7. PubMed ID: 9418761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sunlight, skin cancer and vitamin D: What are the conclusions of recent findings that protection against solar ultraviolet (UV) radiation causes 25-hydroxyvitamin D deficiency in solid organ-transplant recipients, xeroderma pigmentosum, and other risk groups?
    Reichrath J
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):664-7. PubMed ID: 17204418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of vitamin D deficiency in patients with basal cell nevus syndrome.
    Tang JY; Wu A; Linos E; Parimi N; Lee W; Aszterbaum M; Asgari MM; Bickers DR; Epstein EH
    Arch Dermatol; 2010 Oct; 146(10):1105-10. PubMed ID: 20956641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relation between the protection of the skin against solar ultraviolet light and serum levels of vitamin D in patients with xeroderma pigmentosum].
    Orita M; Satoh Y; Mitoh Y; Kawada A; Matsutani H; Abe E; Suda T
    Nihon Hifuka Gakkai Zasshi; 1987 Aug; 97(9):1037-9. PubMed ID: 3430798
    [No Abstract]   [Full Text] [Related]  

  • 6. Vitamin D levels of XP-patients under stringent sun-protection.
    Hoesl M; Dietz K; Röcken M; Berneburg M
    Eur J Dermatol; 2010; 20(4):457-60. PubMed ID: 20494856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xeroderma pigmentosum skin: an immune privilege site for tumor development.
    Abid K; El Mezni F; Kamoun MR; Fazaa B; Zermani R; Hadouchi C; Hamzaoui K
    J Cutan Pathol; 2010 Apr; 37(4):452-9. PubMed ID: 19719835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of vitamin D deficiency in patients with xeroderma pigmetosum-A under strict sun protection.
    Kuwabara A; Tsugawa N; Tanaka K; Uejima Y; Ogawa J; Otao N; Yamada N; Masaki T; Nishigori C; Moriwaki S; Okano T
    Eur J Clin Nutr; 2015 Jun; 69(6):693-6. PubMed ID: 25669318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
    Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The present status of xeroderma pigmentosum in Japan and a tentative severity classification scale.
    Nakano E; Masaki T; Kanda F; Ono R; Takeuchi S; Moriwaki S; Nishigori C
    Exp Dermatol; 2016 Aug; 25 Suppl 3():28-33. PubMed ID: 27539899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iatrogenic vitamin D deficiency in a patient with Gorlin syndrome: the conundrum of photoprotection.
    Gentzsch S; Kern JS; Loeckermann S; Geissler E; Seufert J; Bernard C; Kohlhase J; Bruckner-Tuderman L; Meiss F
    Acta Derm Venereol; 2014 Jul; 94(4):459-60. PubMed ID: 24202285
    [No Abstract]   [Full Text] [Related]  

  • 12. [Etretinate and the prevention of skin cancers].
    Verret JL
    Ther Umsch; 1986 Sep; 43(9):699-702. PubMed ID: 3535154
    [No Abstract]   [Full Text] [Related]  

  • 13. Dermoscopy for the pediatric dermatologist, part ii: dermoscopy of genetic syndromes with cutaneous manifestations and pediatric vascular lesions.
    Haliasos EC; Kerner M; Jaimes N; Zalaudek I; Malvehy J; Lanschuetzer CM; Hinter H; Hofmann-Wellenhof R; Braun RP; Marghoob AA
    Pediatr Dermatol; 2013; 30(2):172-81. PubMed ID: 22994304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sunlight-induced cancer: some new aspects and implications of the xeroderma pigmentosum model.
    Lehmann AR; Bridges BA
    Br J Dermatol; 1990 Apr; 122 Suppl 35():115-9. PubMed ID: 2186779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer in families with xeroderma pigmentosum.
    Swift M; Chase C
    J Natl Cancer Inst; 1979 Jun; 62(6):1415-21. PubMed ID: 286113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XERODERMA PIGMENTOSUM WITH OCULAR COMPLICATIONS.
    SEVEL D
    Br J Ophthalmol; 1963 Nov; 47(11):687-9. PubMed ID: 14211670
    [No Abstract]   [Full Text] [Related]  

  • 17. Xeroderma pigmentosum.
    Norgauer J; Idzko M; Panther E; Hellstern O; Herouy Y
    Eur J Dermatol; 2003; 13(1):4-9. PubMed ID: 12609773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous angiosarcoma in a patient with xeroderma pigmentosum.
    Marcon I; Collini P; Casanova M; Meazza C; Ferrari A
    Pediatr Hematol Oncol; 2004; 21(1):23-6. PubMed ID: 14660303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinase-13 and Ki-67 in nonmelanoma skin cancer in xeroderma pigmentosum and non-xeroderma pigmentosum.
    El-Hawary AK; Yassin E; Khater A; Abdelgaber S
    Am J Dermatopathol; 2013 Feb; 35(1):45-9. PubMed ID: 22722466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma and other skin cancers in xeroderma pigmentosum patients and mutation in their cells.
    Takebe H; Nishigori C; Tatsumi K
    J Invest Dermatol; 1989 May; 92(5 Suppl):236S-238S. PubMed ID: 2715657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.